Properties of Assayed Human Cell Lines
| Cell Line . | Description . | GM-CSF Dependence . | Reference . |
|---|---|---|---|
| HL60 | Acute myelogenous leukemia | − | 25 |
| HL60neo | HL60 with neo resistance | − | 26 |
| HL60/VCR | HL60 resistant to vincristine | − | 25 |
| HL60/Bcl2 | HL60 with Bcl2 transgene | − | 26 |
| HL60/BclXL | HL60 with BclXL transgene | − | 27 |
| K562 | Chronic myelogenous leukemia | − | 48 |
| KB | Mouth epidermoid carcinoma | − | 49 |
| CEM | T-lymphoblastic leukemia | − | 50 |
| HEL92.1.7 | Erythroleukemia | − | 51 |
| TF1 | Erythroleukemia | + | 52 |
| U937 | Monocytic leukemia | − | 53 |
| THP-1 | Acute monocytic leukemia | − | 54 |
| KG-1 | Acute myelogenous leukemia | − | 55 |
| AML193 | Acute monocytic leukemia | + | 56 |
| LS174T | Colon carcinoma | − | 57 |
| Cell Line . | Description . | GM-CSF Dependence . | Reference . |
|---|---|---|---|
| HL60 | Acute myelogenous leukemia | − | 25 |
| HL60neo | HL60 with neo resistance | − | 26 |
| HL60/VCR | HL60 resistant to vincristine | − | 25 |
| HL60/Bcl2 | HL60 with Bcl2 transgene | − | 26 |
| HL60/BclXL | HL60 with BclXL transgene | − | 27 |
| K562 | Chronic myelogenous leukemia | − | 48 |
| KB | Mouth epidermoid carcinoma | − | 49 |
| CEM | T-lymphoblastic leukemia | − | 50 |
| HEL92.1.7 | Erythroleukemia | − | 51 |
| TF1 | Erythroleukemia | + | 52 |
| U937 | Monocytic leukemia | − | 53 |
| THP-1 | Acute monocytic leukemia | − | 54 |
| KG-1 | Acute myelogenous leukemia | − | 55 |
| AML193 | Acute monocytic leukemia | + | 56 |
| LS174T | Colon carcinoma | − | 57 |